Search

everythinglearnresearchcommunity

for

Search:↓

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The man's symptoms improved significantly after penicillin treatment for syphilis.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Skin diseases are common in HIV patients and could help detect HIV early in Ethiopia.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

The man's symptoms improved after treating his scurvy with high-dose vitamin C.

Dermatologists should be involved in the care of hematology patients due to common skin issues.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Immunotherapy can help treat severe alopecia areata.

HIV-infected men who have sex with men are at higher risk for aggressive syphilis, but treatment and tests are effective.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Azithromycin can rarely cause a severe drop in white blood cells.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.